Literature DB >> 17322062

Gene body-specific methylation on the active X chromosome.

Asaf Hellman1, Andrew Chess.   

Abstract

Differential DNA methylation is important for the epigenetic regulation of gene expression. Allele-specific methylation of the inactive X chromosome has been demonstrated at promoter CpG islands, but the overall pattern of methylation on the active X(Xa) and inactive X (Xi) chromosomes is unknown. We performed allele-specific analysis of more than 1000 informative loci along the human X chromosome. The Xa displays more than two times as much allele-specific methylation as Xi. This methylation is concentrated at gene bodies, affecting multiple neighboring CpGs. Before X inactivation, all of these Xa gene body-methylated sites are biallelically methylated. Thus, a bipartite methylation-demethylation program results in Xa-specific hypomethylation at gene promoters and hypermethylation at gene bodies. These results suggest a relationship between global methylation and expression potentiality.

Entities:  

Mesh:

Year:  2007        PMID: 17322062     DOI: 10.1126/science.1136352

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  302 in total

1.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells.

Authors:  R David Hawkins; Gary C Hon; Leonard K Lee; Queminh Ngo; Ryan Lister; Mattia Pelizzola; Lee E Edsall; Samantha Kuan; Ying Luu; Sarit Klugman; Jessica Antosiewicz-Bourget; Zhen Ye; Celso Espinoza; Saurabh Agarwahl; Li Shen; Victor Ruotti; Wei Wang; Ron Stewart; James A Thomson; Joseph R Ecker; Bing Ren
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 2.  Next-generation genomics: an integrative approach.

Authors:  R David Hawkins; Gary C Hon; Bing Ren
Journal:  Nat Rev Genet       Date:  2010-07       Impact factor: 53.242

3.  Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection.

Authors:  Sohachi Nanjo; Kiyoshi Asada; Satoshi Yamashita; Takeshi Nakajima; Kazuyuki Nakazawa; Takao Maekita; Masao Ichinose; Toshiro Sugiyama; Toshikazu Ushijima
Journal:  Gastric Cancer       Date:  2012-01-12       Impact factor: 7.370

Review 4.  The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.

Authors:  Eriona Hysolli; Yong Wook Jung; Yoshiaki Tanaka; Kun-Yong Kim; In-Hyun Park
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

5.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

6.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood.

Authors:  Gidon Toperoff; Dvir Aran; Jeremy D Kark; Michael Rosenberg; Tatyana Dubnikov; Batel Nissan; Julio Wainstein; Yechiel Friedlander; Ephrat Levy-Lahad; Benjamin Glaser; Asaf Hellman
Journal:  Hum Mol Genet       Date:  2011-10-12       Impact factor: 6.150

7.  Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.

Authors:  Masako Suzuki; Mayumi Oda; María-Paz Ramos; Marién Pascual; Kevin Lau; Edyta Stasiek; Frederick Agyiri; Reid F Thompson; Jacob L Glass; Qiang Jing; Richard Sandstrom; Melissa J Fazzari; R Scott Hansen; John A Stamatoyannopoulos; Andrew S McLellan; John M Greally
Journal:  Genome Res       Date:  2011-09-28       Impact factor: 9.043

Review 8.  Functions of DNA methylation: islands, start sites, gene bodies and beyond.

Authors:  Peter A Jones
Journal:  Nat Rev Genet       Date:  2012-05-29       Impact factor: 53.242

Review 9.  Epigenetic programming and risk: the birthplace of cardiovascular disease?

Authors:  Maria Cristina Vinci; Gianluca Polvani; Maurizio Pesce
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 10.  Random and non-random monoallelic expression.

Authors:  Andrew Chess
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.